News > CIPLA scales up Remdesivir production due to surge in demand

CIPLA scales up Remdesivir production due to surge in demand

CNBC TV18 | 13/04/2021 11:32 AM | Click to read full article

Indian drug giant CIPLA said that it has scaled up the production of Remdesvir by 2X from the last wave of the COVID-19 pandemic. CIPLA said it is also facing a shortage of drug Tocilizumab given the spike in cases and a surge in demand.

"We expect some more receipts of supply at the earliest," CIPLA said.